Prostatis Group’s Goldman Sachs ActiveBeta International Equity ETF GSIE Stock Holding History

Prostatis Group’s Portfolio GSIE Stock Details GSIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.12M	Sell	46,368 -391	-0.8%	-$17.8K	0.49%	47
2026 Q1	$2.02M	Sell	46,759 -2,234	-5%	-$99.2K	0.52%	49
2025 Q4	$2.1M	Buy	48,993 +2,329	+5%	+$97.2K	0.5%	47
2025 Q3	$1.92M	Buy	46,664 +597	+1%	+$24.1K	0.48%	51
2025 Q2	$1.83M	Buy	46,067 +23,235	+102%	+$875K	0.52%	50
2025 Q1	$814K	Buy	22,832 +5,325	+30%	+$188K	0.26%	76
2024 Q4	$584K	Buy	+17,507	New	+$605K	0.17%	96

Other funds holding GSIE

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

VIA

Vantagepoint Investment Advisers Washington, District of Columbia $13.4B AUM 22.25% 1-Year Est. Return

SWM

SigFig Wealth Management San Francisco, California $3.77B AUM 15.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Betterment LLC New York $59.1B AUM 18.41% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Prostatis Group's GSIE Position: Q2 2026 in Review

Prostatis Group reduced its Goldman Sachs ActiveBeta International Equity ETF (GSIE) stake by 0.84% in Q2 2026, selling an estimated $17.8K and leaving 46,368 shares worth $2.12M. The position accounts for 0.49% of the portfolio, ranked #47.

Prostatis Group first reported a position in GSIE in Q4 2024 and has held it in 7 quarters since. 349 funds tracked by Wall St. Rank hold GSIE as of Q2 2026.

Prostatis Group held 46,368 shares of Goldman Sachs ActiveBeta International Equity ETF worth $2.12M as of Q2 2026.
Prostatis Group sold 391 Goldman Sachs ActiveBeta International Equity ETF shares in Q2 2026, an estimated $17.8K.
Goldman Sachs ActiveBeta International Equity ETF made up 0.49% of Prostatis Group's portfolio in Q2 2026, its #47 holding.
Prostatis Group first reported a position in Goldman Sachs ActiveBeta International Equity ETF in Q4 2024 and has held it in 7 quarters since.
349 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta International Equity ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.